Gastric Volvulus Treatment, Growth, Opportunity, Global Market Report 2025 to 2034

Gastric Volvulus Treatment

What is the Gastric Volvulus Treatment Market Size and Predicted Growth?
The gastric volvulus treatment market size has grown strongly in recent years. The sector will rise from $27.36 billion in 2024 to $28.95 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth can be attributed to advancements in surgical techniques, improved diagnostic technologies, awareness and education, rise in minimally invasive procedures, research, and clinical studies.

The gastric volvulus treatment market size is projected to see strong growth in the next few years. It will increase to $37.48 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to regulatory changes and approvals, innovations in surgical procedures, growing geriatric population, customized treatment plans, and the adoption of advanced imaging techniques. Major trends in the forecast period include minimally invasive surgical techniques, awareness and early intervention, research in treatment modalities, collaborative medical practices, and customized treatment approaches.

Take advantage of our free sample report: https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What is the Major Driver for Gastric Volvulus Treatment Market Growth?
A rising geriatric population is expected to propel the growth of the gastric volvulus treatment market. The geriatric population refers to older adults 65 years and beyond who suffer from various diseases due to low immunity and age. Gastric volvulus occurs predominantly in older adults over the age of 50. As per the statistics published by the Population Reference Bureau, the number of Americans 65 and older will increase from 58 million in 2022 to 82 million in 2050, a 47% increase, driving the market for gastric volvulus treatment.

What are the Key Segments in the Gastric Volvulus Treatment Market?
1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

Which Key Companies Operate in the Gastric Volvulus Treatment Market?
Major companies in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc.

What Emerging Trends Are Affecting the Gastric Volvulus Treatment Market?
Product innovations are a key trend in the gastric volvulus treatment market. Major companies are introducing innovative products to maintain their market position. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company, announced the FDA approval of VELSIPITY (etrasimod), a once-daily oral sphingosine-1-phosphate receptor activator for individuals with moderate to severe active ulcerative colitis. These innovations mark a turning point for patients in need of new therapies for long-term illnesses.

Which Region Will Lead the Gastric Volvulus Treatment Market?
North America was the largest region in the gastric volvulus market in 2024. However, Asia-Pacific is expected to be the fastest-growing region in the forecasted period.

Market Definition: What Does The Gastric Volvulus Treatment Market Report 2025 Offer?
Gastric volvulus treatment refers to surgical treatment, specifically volvulus reduction, reintegration of the stomach into the abdominal cavity in cases of intrathoracic migration, and correction of causal factors. Gastric volvulus surgery is generally simple, involving de-rotation, lowering of the hernial contents into the abdominal wall, and repair of the hernial defect. The Gastric Volvulus Treatment Market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.

Purchase the exclusive report now to unlock crucial market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

About The Business Research Company
The Business Research Company, a trusted research firm with over 15000+ reports from 27 industries covering 60+ geographies, delivers comprehensive and data-rich research and insights. With 1,500,000 datasets, valuable secondary research, and unique insights from industry leaders, you get the information you need to stay ahead.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model